The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Covid-19 Man­u­fac­tur­ing Roundup: Ther­mo Fish­er plant ramps up As­traZeneca vac­cine pro­duc­tion; No­vavax ex­pands Ko­re­an man­u­fac­tur­ing pact

5 years ago
Coronavirus

End­points Man­u­fac­tur­ing: 5 Ques­tions with Ho­mol­o­gy Med­i­cines

5 years ago
People

Mallinck­rodt be­comes the lat­est vic­tim of the FDA's pan­dem­ic-re­lat­ed de­lays as it push­es off ap­pli­ca­tion for skin graft

5 years ago
Pharma
FDA+

Is­raeli API mak­er Wave­length buys up ma­jor­i­ty stake in In­di­an firm mak­ing drug start­ing ma­te­ri­als and in­ter­me­di­ates

5 years ago
Outsourcing

End­points Man­u­fac­tur­ing: Charles Riv­er makes a splash for cell and gene ther­a­py spe­cial­ist; 5 ques­tions with Ho­mol­o­gy Med­i­cines

5 years ago

Cen­tu­ry Ther­a­peu­tics boosts iP­SC man­u­fac­tur­ing space in New Jer­sey as part of com­pa­ny wide ex­pan­sion

5 years ago
Cell/Gene Tx

Charles Riv­er Lab­o­ra­to­ries snaps up Cog­nate for a cool $875M, looks to ex­pand cell and gene ther­a­py CD­MO foothold

5 years ago
Deals

Hous­ton's Avance Bio­sciences an­nounces an­oth­er ex­pan­sion, this time fo­cused on cell-based as­says

5 years ago

FDA slaps Flori­da's Al­lay Phar­ma­ceu­ti­cals with warn­ing let­ter over vague re­spons­es to drug po­ten­cy is­sues

5 years ago
FDA+

Vi­gene Bio­sciences goes big on Mary­land vi­ral vec­tor ex­pan­sion as it rides high on Al­tim­mune vac­cine deal

5 years ago

End­points Man­u­fac­tur­ing: Lon­za drops in­gre­di­ents biz in $4.7B sale; Touch­light's 'dog­gy­boneD­NA' looks to rewrite rules of ther­a­peu­tic DNA

5 years ago

Ger­many's Rentschler looks to build UK foot­print with five-year in­vest­ment in cell and gene ther­a­pies

5 years ago
Deals

Quo­tient, buoyed by Covid-19 work, buys Ar­ci­no­va in ef­fort to build end-to-end CD­MO brand

5 years ago
Deals

Fre­se­nius Kabi pays $50 mil­lion to set­tle crim­i­nal charges

5 years ago
FDA+

In­di­a's TCG launch­es new CD­MO arm state­side to meet the call for 'Amer­i­can-made' pan­dem­ic drugs

5 years ago

As­traZeneca looks to re­bound from pro­duc­tion de­lays for its Covid-19 vac­cine with new fill-fin­ish deal

5 years ago
Outsourcing
Coronavirus

Lon­za of­floads spe­cial­ty in­gre­di­ents unit in $4.7B sale to Bain Cap­i­tal, Cin­ven in con­sol­i­da­tion around bio­phar­ma

5 years ago
Outsourcing

Se­qens ma­jor­i­ty own­er look­ing to sell API mak­er amid record-high run in health­care val­u­a­tions: re­port

5 years ago
Deals

Mer­ck KGaA ex­pands its deal with Pfiz­er/BioN­Tech with an eye on a key vac­cine man­u­fac­tur­ing bot­tle­neck

5 years ago
Coronavirus

FDA cites litany of er­rors at Lon­za Hous­ton plant at the cen­ter of Bris­tol My­ers CVR de­ba­cle

5 years ago
FDA+

Rapid CD­MO growth marks a start to End­points Man­u­fac­tur­ing's first re­port — here's what to ex­pect from our cov­er­age

5 years ago

Re­call re­port: Apo­tex re­calls 2 batch­es of blood-thin­ner in­jec­tion af­ter sy­ringe mis­la­bel­ing sna­fu

5 years ago
FDA+

Glax­o­SmithK­line dou­bles down on Cure­Vac's mR­NA tech, bets $180M on the hunt for next-gen vac­cine

5 years ago
Deals
Coronavirus

WuXi STA snaps up Bris­tol My­ers Squibb fa­cil­i­ty, plants feet in Eu­ro­pean CD­MO mar­ket­place

5 years ago
Deals
First page Previous page 767778798081 Next page Last page
A service from the Financial Times